S-EPMC12903676 - Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer. - OmicsDI

Unknown

Dataset Information

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

ABSTRACT:

SUBMITTER: Taddei I

PROVIDER: S-EPMC12903676 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature